Skip to main content

previous disabled Page of 2
and
Your search also matched 6 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Therapie der Tuberkulose: Was gibt es Neues?

Include preview-only content
  1. Article

    Open Access

    Gentamicin combination treatment is associated with lower mortality in patients with invasive listeriosis: a retrospective analysis

    Listeria monocytogenes causes severe bacterial infections with the highest mortality rate among foodborne pathogens in Europe. Combination treatment with ampicillin and gentamicin is recommended for invasive mani...

    Jan P. Sutter, Lorenz Kocheise, Jan Kempski, Martin Christner in Infection (2024)

  2. Article

    Open Access

    High burden of RSV and influenza in patients presenting with suspected pneumonia in the emergency room of a German tertiary hospital in fall of 2022

    Bacterial pneumonia, a major cause of respiratory tract infections (RTI), can be challenging to diagnose and to treat adequately, especially when seasonal viral pathogens co-circulate. The aim of this study wa...

    Marlene Ettemeyer, Maria Florey, Konstantin Tanida, Johannes Jochum in Infection (2023)

  3. Article

    Open Access

    Tecovirimat for the treatment of severe Mpox in Germany

    In May 2022, a multi-national mpox outbreak was reported in several non-endemic countries. The only licensed treatment for mpox in the European Union is the orally available small molecule tecovirimat, which in O...

    Lennart Hermanussen, Thomas Theo Brehm, Timo Wolf, Christoph Boesecke in Infection (2023)

  4. Article

    Open Access

    Disseminated tuberculosis during TNF-α inhibitor therapy diagnosed by positron emission tomography and mini-laparoscopy

    Lennart Hermanussen, Thomas Theo Brehm, Stefan Schmiedel in Infection (2023)

  5. Article

    Open Access

    Orthopox simiae muscle abscess

    Thomas Theo Brehm, Lennart Hermanussen, Stefan Schmiedel in Infection (2023)

  6. Article

    Open Access

    Mini-laparoscopy as a diagnostic tool for abdominal tuberculosis: a retrospective series of 29 cases

    Abdominal tuberculosis (TB) is a “great mimic,” and diagnosis remains challenging even for experienced clinicians. While mini-laparoscopy has already been demonstrated to be an efficient diagnostic tool for a ...

    Thomas Theo Brehm, Natascha Ndzedzeka-Völz, Malte Wehmeyer in Surgical Endoscopy (2023)

  7. Article

    Open Access

    Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

    Patients with cancer are at high risk of severe coronavirus disease 2019 (COVID-19), with high morbidity and mortality. Furthermore, impaired humoral response renders severe acute respiratory syndrome coronavi...

    Claudia M. Denkinger, Maike Janssen, Ulrike Schäkel, Julia Gall in Nature Cancer (2023)

  8. Article

    Open Access

    Respiratory muscle dysfunction in long-COVID patients

    Symptoms often persistent for more than 4 weeks after COVID-19—now commonly referred to as ‘Long COVID’. Independent of initial disease severity or pathological pulmonary functions tests, fatigue, exertional i...

    Jan K. Hennigs, Marie Huwe, Annette Hennigs, Tim Oqueka, Marcel Simon in Infection (2022)

  9. Article

    Open Access

    Diagnosis of abdominal tuberculosis by mini-laparoscopy

    Thomas Theo Brehm, Stefan Schmiedel, Ansgar W. Lohse in Infection (2022)

  10. Article

    Open Access

    Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome

    Vaccine development is essential for pandemic preparedness. We previously conducted a Phase 1 clinical trial of the vector vaccine candidate MVA-MERS-S against the Middle East respiratory syndrome coronavirus ...

    Anahita Fathi, Christine Dahlke, Verena Krähling, Alexandra Kupke in Nature Communications (2022)

  11. Article

    Erratum zu: Imitation eines Felty-Syndroms durch eine viszerale Leishmaniasis bei rheumatoider Arthritis unter Therapie mit Methotrexat und Etanercept

    Nikolas Ruffer, Nicola M. Tomas, Stefan Schmiedel in Zeitschrift für Rheumatologie (2022)

  12. Article

    Open Access

    Disturbed lipid and amino acid metabolisms in COVID-19 patients

    The Coronavirus disease 2019 (COVID-19) pandemic is overwhelming the healthcare systems. Identification of systemic reactions underlying COVID-19 will lead to new biomarkers and therapeutic targets for monitor...

    Mojgan Masoodi, Manuela Peschka, Stefan Schmiedel in Journal of Molecular Medicine (2022)

  13. Article

    Open Access

    Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza

    While several studies have described the clinical course of patients with coronavirus disease 2019 (COVID-19), direct comparisons with patients with seasonal influenza are scarce. We compared 166 patients with...

    Thomas Theo Brehm, Marc van der Meirschen, Annette Hennigs in Scientific Reports (2021)

  14. Article

    Open Access

    Wound infection with Vibrio harveyi following a traumatic leg amputation after a motorboat propeller injury in Mallorca, Spain: a case report and review of literature

    Vibrio spp. are aquatic bacteria that are ubiquitous in warm estuarine and marine environments, of which 12 species are currently known to cause infections in humans. So far, only five human infections with V. ha...

    Thomas Theo Brehm, Laura Berneking, Holger Rohde in BMC Infectious Diseases (2020)

  15. Article

    Open Access

    Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study)

    To evaluate clinical outcomes after either immediate or deferred initiation of antiretroviral therapy in HIV-1-infected patients, presenting late with pneumocystis pneumonia (PCP) or toxoplasma encephalitis (TE).

    Guido Schäfer, Christian Hoffmann, Keikawus Arasteh in AIDS Research and Therapy (2019)

  16. Article

    Management der saisonalen Influenza 2017/2018: Erfahrungen an einem deutschen Universitätsklinikum

    Es gibt nur wenige strukturierte klinische Erfahrungsberichte zum stationären Management einer saisonalen Influenzaepidemie.

    Christian Kraef, Marc van der Meirschen in Bundesgesundheitsblatt - Gesundheitsforsch… (2019)

  17. Article

    Open Access

    Screening and contact precautions – A survey on infection control measures for multidrug-resistant bacteria in German university hospitals

    To assess the scope of infection control measures for multidrug-resistant bacteria in high-risk settings, a survey among university hospitals was conducted. Fourteen professionals from 8 sites participated. Re...

    Lena M. Biehl, Hartmut Bertz in Antimicrobial Resistance & Infection Contr… (2017)

  18. Article

    Unique human immune signature of Ebola virus disease in Guinea

    Fatal Ebola virus disease is characterized by a high proportion of CD4+ and CD8+ T cells expressing the inhibitory molecules CTLA-4 and PD-1, correlating with high virus load; individuals who survive the infectio...

    Paula Ruibal, Lisa Oestereich, Anja Lüdtke, Beate Becker-Ziaja, David M. Wozniak in Nature (2016)

  19. Article

    Open Access

    German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

    Current German and European HIV guidelines recommend early evaluation of HCV treatment in all HIV/HCV co-infected patients. However, there are still considerable barriers to initiate HCV therapy in everyday cl...

    Claudia Beisel, Martin Heuer, Benjamin Otto, Johannes Jochum in AIDS Research and Therapy (2014)

  20. Article

    Open Access

    Safety and efficacy of protease inhibitor based combination therapy in a single-center “real-life” cohort of 110 patients with chronic hepatitis C genotype 1 infection

    The combination of boceprevir or telaprevir with peginterferon-alfa and ribavirin for the treatment of patients infected with HCV genotype 1 has led to significantly increased rates of sustained virological re...

    Malte H Wehmeyer, Friederike Eißing, Sabine Jordan, Claudia Röder in BMC Gastroenterology (2014)

previous disabled Page of 2